28 related articles for article (PubMed ID: 26757124)
1. Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.
Guo J; Thiess S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
FEBS Lett; 2016 Feb; 590(3):330-9. PubMed ID: 26787547
[TBL] [Abstract][Full Text] [Related]
2. Heterologous expression of human cytochrome P450 2S1 in
Mrízová I; Moserová M; Milichovský J; Šulc M; Kizek R; Kubáčková K; Arlt VM; Stiborová M
Monatsh Chem; 2016; 147():881-888. PubMed ID: 27110039
[TBL] [Abstract][Full Text] [Related]
3. Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.
Szaefer H; Licznerska B; Cykowiak M; Baer-Dubowska W
Pharmacol Rep; 2019 Dec; 71(6):1001-1005. PubMed ID: 31561186
[TBL] [Abstract][Full Text] [Related]
4. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
5. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.
Aiyappa-Maudsley R; Storr SJ; Rakha EA; Green AR; Ellis IO; Martin SG
J Pathol Clin Res; 2022 Nov; 8(6):550-566. PubMed ID: 35902379
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia as a modulator of cytochromes P450: Overexpression of the cytochromes CYP2S1 and CYP24A1 in human liver cancer cells in hypoxia.
Cabrera-Cano A; Dávila-Borja VM; Juárez-Méndez S; Marcial-Quino J; Gómez-Manzo S; Castillo-Rodríguez RA
Cell Biochem Funct; 2021 Jun; 39(4):478-487. PubMed ID: 33377261
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
8. Preparation and application of anti-peptide antibodies for detection of orphan cytochromes P450.
Hodek P; Hrdinova J; Macova I; Soucek P; Mrizova I; Burdova K; Kizek R; Hudecek J; Stiborova M
Neuro Endocrinol Lett; 2015; 36 Suppl 1():38-45. PubMed ID: 26757124
[TBL] [Abstract][Full Text] [Related]
9. CYP2S1: a short review.
Saarikoski ST; Rivera SP; Hankinson O; Husgafvel-Pursiainen K
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):62-9. PubMed ID: 16054184
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
11. A Review on the Expression and Metabolic Features of Orphan Human Cytochrome P450 2S1 (CYP2S1).
Yan P; Eng OC; Yu CJ
Curr Drug Metab; 2018; 19(11):917-929. PubMed ID: 29804525
[TBL] [Abstract][Full Text] [Related]
12. Novel extrahepatic cytochrome P450s.
Karlgren M; Miura S; Ingelman-Sundberg M
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
